BridgeBio Pharma (NASDAQ:BBIO) CEO Neil Kumar Sells 26,103 Shares
MarketBeat
BridgeBio Pharma, Inc. (NASDAQ:BBIO - Get Free Report) CEO Neil Kumar sold 26,103 shares of the company's stock in a transaction on Thursday, May 21st. The shares were sold at an average price of $69.44, for a total transaction of $1,812,592.32. Following the completion of the sale, the chief executive officer directly owned 243,327 shares of the company's stock, valued at $16,896,626.88. This trade represents a 9.69% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
NASDAQ:BBIO